Pictet Asset Management
PVLA

Pictet Asset Management’s Palvella Therapeutics PVLA Stock Holding History

Pictet Asset Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
+1,331
New +$162K ﹤0.01% 1989

Other funds holding PVLA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
CAM
Clio Asset Management Charlottesville, Virginia $126M AUM 16.01% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

Pictet Asset Management's PVLA Position: Q2 2026 in Review

Pictet Asset Management opened a new position in Palvella Therapeutics (PVLA) in Q2 2026: 1,331 shares worth $203K. The stake represents ﹤0.01% of the portfolio and ranks #1989 among its holdings.

67 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Pictet Asset Management held 1,331 shares of Palvella Therapeutics worth $203K as of Q2 2026.
  • Palvella Therapeutics was a new Pictet Asset Management position in Q2 2026.
  • Palvella Therapeutics made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1989 holding.
  • 67 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.